Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 7,060.00
-590.00 (-7.71%)
At close: Apr 30, 2026
151.25% (1Y)
| Market Cap | 246.34B +252.2% |
| Revenue (ttm) | 24.59B -11.4% |
| Net Income | -6.43B |
| EPS | -205.00 |
| Shares Out | 34.89M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 654,414 |
| Average Volume | 619,903 |
| Open | 7,630.00 |
| Previous Close | 7,650.00 |
| Day's Range | 6,970.00 - 7,650.00 |
| 52-Week Range | 2,440.00 - 10,180.00 |
| Beta | 0.56 |
| RSI | 49.90 |
| Earnings Date | Nov 14, 2025 |